mounjaro tirzepatide mechanism of action (Mounjaro/Zepbound): Research Guide The promise of tirzepatide: A
Description
Sources BBC (16 May 2019)
Struggling with weight gain despite eating well and exercising
GLP-1 agonists are approved for the treatment of diabetes and for obesity
For patients who respond better to a pure GLP-1 agonist without the GIP receptor activity that tirzepatide adds, semaglutide may actually be the better choice
Patients with prior GI conditions may experience delayed tolerance development or need modified dose-escalation strategies tailored to their risk profile
If you find yourself in this cycle, try eating a small breakfast and then additional small meals every 3-4 hours while drinking plenty of fluids
